TLR7 and non-small cell lung carcinoma: In particular, we evaluated tubule formation in vitro in response to CM of NSCLC cells silenced for TLR7 (shTLR7) or stimulated by imiquimod (1 μg/mL), a selective agonist to TLR7 [28,29], compared to the relative controls.